Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti-versus Pro-Tumoral Activities

被引:50
|
作者
Xiang, Zheng [1 ]
Tu, Wenwei [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Lab Translat Immunol, Hong Kong, Hong Kong, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2017年 / 8卷
关键词
V gamma 9V delta 2-T cells; antitumor activity; pro-tumor activity; tumor immunity; tumor immunotherapy; DELTA-T-CELLS; TCR-GAMMA-DELTA; PRENYL PYROPHOSPHATE ANTIGENS; BREAST-CANCER PATIENTS; EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD; ADOPTIVE IMMUNOTHERAPY; IMMUNE-RESPONSES; ZOLEDRONIC ACID; DENDRITIC-CELLS;
D O I
10.3389/fimmu.2017.01041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
V gamma 9V delta 2-T cells are considered as potent effector cells for tumor immunotherapy through directly killing tumor cells and indirectly regulating other innate and adaptive immune cells to establish antitumoral immunity. The antitumoral activity of V gamma 9V delta 2-T cells is governed by a complicated set of activating and inhibitory cell receptors. In addition, cytokine milieu in tumor microenvironment can also induce the pro-tumoral activities and functional plasticity of V gamma 9V delta 2-T cells. Here, we review the anti-versus pro-tumoral activities of V gamma 9V delta 2-T cells and discuss the mechanisms underlying the recognition, activation, differentiation and regulation of V gamma 9V delta 2-T cells in tumor immunosurveillance. The comprehensive understanding of the dual face of V gamma 9V delta 2-T cells in tumor immunology may improve the therapeutic efficacy and clinical outcomes of V gamma 9V delta 2-T cell-based tumor immunotherapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells
    Cui, Qu
    Shibata, Hironobu
    Oda, Asuka
    Amou, Hiroe
    Nakano, Ayako
    Yata, Kenichiro
    Hiasa, Masahiro
    Watanabe, Keiichiro
    Nakamura, Shingen
    Miki, Hirokazu
    Harada, Takeshi
    Fujii, Shiro
    Kagawa, Kumiko
    Takeuchi, Kyoko
    Ozaki, Shuji
    Matsumoto, Toshio
    Abe, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (01) : 63 - 70
  • [42] Clinical relevance of pro-inflammatory skin homing CLA+ Vγ9Vδ2 T cells in psoriasis
    Laggner, U.
    Di Meglio, P.
    Perera, G. K.
    Hundhausen, C.
    Lacy, K. E.
    Ali, N.
    Smith, C. H.
    Hayday, A. C.
    Nickoloff, B. J.
    Nestle, F. O.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (04) : 907 - 907
  • [43] Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors
    Rafia, Chirine
    Harly, Christelle
    Scotet, Emmanuel
    IMMUNOLOGICAL REVIEWS, 2020, 298 (01) : 117 - 133
  • [44] Characterization of tumor reactivity of human Vγ9Vδ2 yδ T cells in vitro and in SCID mice in vivo
    Kabelitz, D
    Wesch, D
    Pitters, E
    Zöller, M
    JOURNAL OF IMMUNOLOGY, 2004, 173 (11): : 6767 - 6776
  • [45] Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells
    Baker, Forrest L.
    Bigley, Austin B.
    Agha, Nadia H.
    Pedlar, Charles R.
    O'Connor, Daniel P.
    Bond, Richard A.
    Bollard, Catherine M.
    Katsanis, Emmanuel
    Simpson, Richard J.
    FRONTIERS IN IMMUNOLOGY, 2020, 10
  • [46] Targeted Activation of Human Vγ9Vδ2-T Cells Controls Epstein-Barr Virus-Induced B Cell Lymphoproliferative Disease
    Xiang, Zheng
    Liu, Yinping
    Zheng, Jian
    Liu, Ming
    Lv, Aizhen
    Gao, Yulong
    Hu, Huaidong
    Lam, Kowk-Tai
    Chan, Godfrey Chi-Fung
    Yang, Yuanzhong
    Chen, Honglin
    Tsao, George Sai-Wah
    Bonneville, Marc
    Lau, Yu-Lung
    Tu, Wenwei
    CANCER CELL, 2014, 26 (04) : 565 - 576
  • [47] IL-33-expanded human Vγ9Vδ2 T cells have anti-lymphoma effect in a mouse tumor model
    Duault, Caroline
    Betous, Delphine
    Bezombes, Christine
    Roga, Stephane
    Cayrol, Corinne
    Girard, Jean-Philippe
    Fournie, Jean-Jacques
    Poupot, Mary
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 (12) : 2137 - 2141
  • [48] CRTAM Receptor Engagement by Necl-2 on Tumor Cells Triggers Cell Death of Activated Vγ9Vδ2 T Cells
    Dessarth, Benoit
    Thedrez, Aurelie
    Latouche, Jean-Baptiste
    Cabillic, Florian
    Drouet, Aurelie
    Daniel, Pascale
    de la Pintiere, Cecile Thomas
    Catros, Veronique
    Toutiraisx, Olivier
    JOURNAL OF IMMUNOLOGY, 2013, 190 (09): : 4868 - 4876
  • [49] Type 1 Responses of Human Vγ9Vδ2 T Cells to Influenza A Viruses
    Qin, Gang
    Liu, Yinping
    Zheng, Jian
    Ng, Iris H. Y.
    Xiang, Zheng
    Lam, Kwok-Tai
    Mao, Huawei
    Li, Hong
    Peiris, J. S. Malik
    Lau, Yu-Lung
    Tu, Wenwei
    JOURNAL OF VIROLOGY, 2011, 85 (19) : 10109 - 10116
  • [50] Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection
    Soriano-Sarabia, Natalia
    Archin, Nancie M.
    Bateson, Rosalie
    Dahl, Noelle P.
    Crooks, Amanda M.
    Kuruc, JoAnn D.
    Garrido, Carolina
    Margolis, David M.
    PLOS PATHOGENS, 2015, 11 (10)